Aesthetics

New York - Meticulous attention to technique is probably the most important rule for avoiding complications when treating patients with botulinum toxin for cosmetic indications, says Neil S. Sadick, M.D.

Albert M. Kligman, M.D., Ph.D.'s 'accidental' discovery of tretinoin moved drug well beyond acne treatment

Internationally recognized researcher, Alan Menter, M.D., considers the future of psoriasis treatment.

Alan Shalita, M.D., Ph.D., a leader in acne research, has studied the condition for more than 30 years.

Albert Kligman, M.D., Ph.D., explores pigmentary disorders and develops enduring treatments

Albert Kligman, M.D., Ph.D., is a pioneer who continues to break new ground in dermatology.

Dermatologic cosmetic lasers have revolutionized the practice of dermatology. By providing treatment for many skin conditions once thought to be untreatable, these surgical tools are now highly regarded-and commonly used-in many cosmetic dermatology practices.

New Yorkers, especially, will sacrifice results for speed

Tool offers shorter recovery time, fewer risks, less cost

Patients report smoother skin after single application

The incision extends from the sideburn, around the ear, and two-thirds up the post-auricular crease. As a consequence of its longer incision, the short scar facelift offers many advantages compared to the S-Lift, Dr. Morganroth says.

Stanford, Calif. - Skin cancer in immunosuppressed solid organ transplant recipients is a significant problem and one of growing importance as patient survival post-transplantation continues to increase, says Daniel Berg, M.D

Improvement continues even after 32 weeks; technique gains acceptance for lower face

Many approaches now available to rejuvenate upper, lower face

Dilution, needle selection, patient assessment and proper technique yield quality results

Doctors' expertise grows; patient confidence climbs; options broaden

Uses explode across medical specialties

Poly-L-lactic acid offers durability, volume, dramatic correcting power

The road to finding the perfect filler substance has been bumpy. Experts say researchers are getting close to that ultimate filler, but are not yet there.

Stanford, Calif. - Reports of the efficacy of botulinum toxin type A (Botox, Allergan) injection for the management of focal hyperhidrosis are prompting more patients to seek treatment for excessive sweating, says Daniel Berg, M.D., who spoke on the topic at "The Next Step: Mastering Cutaneous Outpatient Procedures," a continuing education program held at Stanford University.

Dr. (George) Farber says if the tax had been passed in Louisiana, he would have been first in line to challenge it.

A controversial report suggests that Britons should sunbathe daily without sunblock to help prevent disease.

Leeches may now officially be used for medicinal purposes, following recent approval by the U.S. Food and Drug Administration (FDA) for commercial marketing.

Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.

National report - The benefits of Allergan's proposed oral psoriasis drug, Tazoral, do not outweigh possible risks of birth defects and bone loss, a U.S. Food and Drug Administration advisory panel has decided.